Immunotherapy has emerged as one of the most promising approaches for ovarian cancer
treatment. The tumor microenvironment (TME) is a key factor to consider when stimulating …

Often referred to as the silent killer, ovarian cancer is the most lethal gynecologic
malignancy. This disease rarely shows any physical symptoms until late stages and no …

Simple Summary Ovarian cancer (OVCA) is a fatal gynecological disease for which there is
no early detection test. Glucose-regulated protein 78 (GRP78), a protein marker of stress …

The expression of death receptor 6 (DR 6) is abnormal in some cancer types, but the
function and underlying molecular mechanisms of DR 6 in tumor progression are not yet …

Objective Long-term unresolved inflammation has been suggested as a risk factor for the
development of various malignancies. The goal of this study was to examine whether the …

Problem Ovarian cancer (OVCA) disseminates in a distinct pattern through peritoneal
metastasis and little is known about the immunosuppression in the tumor microenvironment …

Ovarian high grade serous carcinoma (HGSC) is a lethal form of ovarian cancer (OVCA). In
most cases it is detected at late stages as the symptoms are non-specific during early …

Limited resolution of transvaginal ultrasound (TVUS) scanning is a significant barrier to early
detection of ovarian cancer (OVCA). Contrast agents have been suggested to improve the …

Tumor-associated neoangiogenesis (TAN) is an early event in ovarian cancer (OVCA)
development. Increased expression of vascular endothelial growth factor receptor 2 …

Background/Aim: Low-grade gliomas (LGG) are heterogenous tumours, causing variable
survivals in patients. Identifying molecular markers for a more accurate prognosis is …